Skip to Content

    Meet Our Corporate Partners

    Meet Our Corporate Partners

    Reaching our vision of a world without Alzheimer’s is a team effort. The generous support of our corporate partners allows us to serve more families and to accelerate research toward methods of treatment, prevention and ⁠— ultimately ⁠— a cure.

    Learn how to become a national corporate partner.

    Featured Corporate Partner

     

    Marshalls Supports the Fight to End Alzheimer's

    From March 8-21, Marshalls customers nationwide have the opportunity to donate or round up at checkout to support the mission of the Alzheimer's Association. Since 2013, Marshalls and its customers have raised critical funds for Alzheimer's care, support and research.

    Learn More

    Visionary Partners

    Eisai logo

    Eisai

    Lilly logo

    Ely Lilly & Company

    Salesforce logo

    Salesforce

    Accelerator Partners

    Biogen logo

    Biogen

    Costco logo

    Costco

    Genentech logo

    Genentech - A Roche Company/Roche Diagnostics

    Novo Nordisk logo

    Novo Nordisk

    Catalyst Partners

    AARP logo

    AARP

    AbbVie logo

    AbbVie

    Acumen Pharmaceuticals logo

    Acumen Pharmaceuticals

    Alzheon logo

    Alzheon

    Athira Pharma, Inc. logo

    Athira Pharma, Inc.

    AWS logo

    AWS

    Beckman Coulter Life Sciences logo

    Beckman Coulter Life Sciences

    Bristol Myers Squibb logo

    Bristol Myers Squibb

    C2N Diagnostics logo

    C2N Diagnostics

    Cogstate logo

    Cogstate

    GE HealthCare logo

    GE HealthCare

    Johnson & Johnson logo

    Johnson & Johnson

    Lundbeck logo

    Lundbeck

    Molina Healthcare logo

    Molina Healthcare

    Prothena Biosciences logo

    Prothena Biosciences

    UnitedHealth Group logo

    UnitedHealth Group

    Volta Oil logo

    Volta Oil

    Mission Leader Partners

    Diagnostic and Pharmaceutical Corporate Donors

    No contribution from any entity impacts the Alzheimer's Association decision-making, nor our positions on issues related to people living with Alzheimer’s, other dementia and their families. Total contributions from the pharmaceutical industry make up just over 1.5% of the Association’s total contributed revenue. View the report that discloses pharmaceutical, biotech, medical device, medical application, medical foods, nutraceutical company and clinical research contributions during the past fiscal year.